Group 1 - Prothena (PRTA) closed at $9.4, with a 5.5% gain over the past four weeks, and a mean price target of $20.5 suggests an 118.1% upside potential [1] - The mean estimate includes six short-term price targets with a standard deviation of $10.65, indicating variability; the lowest estimate is $8.00 (14.9% decline), while the highest is $36.00 (283% increase) [2] - Analysts show strong agreement on PRTA's ability to report better earnings, with a positive trend in earnings estimate revisions indicating potential upside [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 73.3%, with three estimates moving higher and no negative revisions [12] - PRTA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, it does provide a directional guide for price movement [14]
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade